Jan Daneš
Charles University in Prague
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jan Daneš.
IEEE Transactions on Image Processing | 2009
Jirí Grim; Petr Somol; Michal Haindl; Jan Daneš
We propose a new approach to diagnostic evaluation of screening mammograms based on local statistical texture models. The local evaluation tool has the form of a multivariate probability density of gray levels in a suitably chosen search window. First, the density function in the form of Gaussian mixture is estimated from data obtained by scanning of the mammogram with the search window. Then we evaluate the estimated mixture at each position and display the corresponding log-likelihood value as a gray level at the window center. The resulting log-likelihood image closely correlates with the structural details of the original mammogram and emphasizes unusual places. We assume that, in parallel use, the log-likelihood image may provide additional information to facilitate the identification of malignant lesions as untypical locations of high novelty.
Breast Cancer Research and Treatment | 2002
Luboslava Krasna; D. Dudorkinová; J. Vedralová; P. Veselý; E. Pokorná; I. Kudláčková; Alena Chaloupkova; L. Petruželka; Jan Daneš; Eva Matouskova
Regular expansion of heterogeneous populations of epithelial cells, including the luminal phenotype, was achieved from small biopsies of human breast tumours and cutaneous metastases by optimized feeder layer technique based on irradiated NIH 3T3 cells. Forty-one out of 47 primary tumour specimens and all three cutaneous metastases grew successfully for two to 10 passages in vitro. The main phenotypes of cultured cells and their changes in subcultures were characterized using immunocytochemistry and phase contrast microscopy (in few cases also time-lapse recording). In the majority of cultured cell populations a fraction of cells positive for keratin 19 (K19+), typical for the luminal phenotype, was detected. This is the cell type from which breast carcinoma is supposed to arise. While in cultures derived from benign lesions only basic phenotypes of luminal and myoepithelial cells were found, in cultures derived from malignant tumours unusual phenotypes of epithelial cells, in their majority K19+, were detected. The growth properties of cells from six benign and seven malignant samples were analyzed in detail. In the analyzed cell populations the culture lifetime – related to the number of colony-forming cells – varied for cells from malignant tumours between 21 and 51 and from benign tumours between 22 and 40 cell generations. The total number of passages achieved was three to seven for malignant or four to nine for benign cultures. In spite of negative results of tumourigenicity testing in immunologically compromised Nu/nu mice the potential to culture apparently neoplastic cells was indicated by positive immunostaining for the p53 oncoprotein (seven of 23 tested malignant cases), the src oncoprotein (five of eight), and overexpression of the c-erbB-2 protein (five of 26). This was further confirmed by successful cultivation of malignant cells from cutaneous metastases. Two of the three metastasis-derived cultures were nearly homogeneously positive for K19 while the third was almost negative. The results proved the optimized feeder layer technique to be useful for regular yielding of large amounts of epithelial cells from small tumour biopsies and for supporting the majority of cell phenotypes present in the original tumour. Therefore, it appeared to be a promising tool for further analysis of interactions between luminal and myoepithelial cells in the development of human breast carcinoma and for the study of individual tumours.
BMC Public Health | 2011
Ondrej Majek; Jan Daneš; Miroslava Skovajsová; Helena Bartonkova; Lucie Burešová; Daniel Klimeš; Petr Brabec; Pavel Kozeny; Ladislav Dušek
BackgroundThe Czech Breast Cancer Screening Programme (CBCSP) was initiated in September 2002 by establishing a network of accredited centres. The aim of this article is to describe progress in the programme quality over time after the inception of the organised programme.MethodsThe CBCSP is monitored using an information system consisting of three principal components: 1) the national cancer registry, 2) a screening registry collecting data on all screening examinations, further assessments and final diagnoses at accredited programme centres, and 3) administrative databases of healthcare payers. Key performance indicators from the European Guidelines have been adopted for continuous monitoring.ResultsBreast cancer incidence in the Czech Republic has steadily been increasing, however with a growing proportion of less advanced stages. The mortality rate has recently stabilised. The screening registry includes 2,083,285 records on screening episodes between 2002 and 2008. In 2007-2008, 51% of eligible women aged 45-69 were screened. In 2008, the detection rates were 6.1 and 3.7 per 1,000 women in initial and subsequent screening respectively. Corresponding recall rates are 3.9% and 2.2%, however, it is necessary to pay attention to further assessment performed during the screening visits. Benign to malignant open biopsy ratio was 0.1. Of invasive cases detected in screening, 35.6% was less than 10 mm in diameter. Values of early performance indicators, as measured by both crude and standardized estimates, are generally improving and fulfil desirable targets set by European Guidelines.ConclusionsMammography screening in the Czech Republic underwent successful transformation from opportunistic prevention to an organised programme. Values of early indicators confirm continuous improvement in different aspects of process quality. Further stimulation of participation through invitation system is necessary to exploit the full potential of screening mammography at the population level.
Iranian Journal of Radiology | 2016
Lukas Lambert; Alena Lambertova; Jan Daneš; Gabriela Grusova
Background Several dedicated computed tomography (CT) colonography phantoms have been described previously. Objectives To compare their pros and cons and describe the construction of a dedicated phantom that can be easily manufactured. Materials and Methods We found 15 different phantom designs by literature search and compared their advantages and disadvantages based on their description and images. We tested various materials for density and mechanical properties and constructed a phantom from polypropylene pipes (30 mm and 50 mm in diameter, 52 cm in length). Haustral folds were created by heat shaping and 39 intermediate sessile polyps with a target size of 6-10 mm and two flat lesions were created from silicone. Nine polyps were attached to a fold. The model was placed in a 30-cm barrel filled with water to simulate attenuation of human body. Attenuation of polyps was compared to intermediate polyps found in patients. Results None of the earlier colonic phantoms found in the literature incorporated all the properties that would ensure both reproducibility and validity of the model (including a rigid wall, density of the wall and polyps similar to human colon, at least two levels of distension and durability). In the present phantom, the average size of sessile polyps was 8.6 ± 0.9 mm and their density was 53 ± 24 HU. We found no significant difference in polyp density between simulated polyps in the phantom and polyps in human subjects (P = 0.70). All polyps, with the exception of one flat lesion, were detected by computer aided detection. Conclusion We constructed and validated a CT colonography phantom with correct density allowing performance of reproducible experiments.
European Radiology | 2017
Francesco Sardanelli; Hildegunn Aase; Marina Álvarez; Edward Azavedo; Henk Jan Baarslag; Corinne Balleyguier; Pascal A. Baltzer; Vanesa Beslagic; Ulrich Bick; Dragana Bogdanovic-Stojanovic; Ruta Briediene; Boris Brkljačić; Julia Camps Herrero; Catherine Colin; Eleanor Cornford; Jan Daneš; Gérard de Geer; Gul Esen; Andrew Evans; Michael H. Fuchsjaeger; Fiona J. Gilbert; Oswald Graf; Gormlaith Hargaden; Thomas H. Helbich; Sylvia H. Heywang-Köbrunner; Valentin Ivanov; Ásbjörn Jónsson; Christiane K. Kuhl; Eugenia C. Lisencu; Elzbieta Luczynska
Breast Cancer Research and Treatment | 2006
Jan Novotny; Ladislav Pecen; Lubos Petruzelka; Adam Svobodník; Ladislav Dušek; Jan Daneš; Miloslava Skovajsova
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti | 2010
Ondřej Májek; Jan Daneš; Miroslav Zavoral; Vladimír Dvořák; Štěpán Suchánek; Bohumil Seifert; Pavel Kožený; Stanislava Pánová; Ladislav Dušek
Anticancer Research | 2003
Luboslava Krasna; Irena Netikova; Alena Chaloupkova; Eva Taislova; Martina Zimovjanova; Pavel Vesely; Jan Daneš; Lubos Petruzelka; Eva Matouskova
Archives of Gynecology and Obstetrics | 2015
Michael Golatta; Aba Harcos; David Pavlista; Jan Daneš; Rafi Klein; Paola Simovich; Ines Gruber; Markus Hahn
Wiener Klinische Wochenschrift | 2017
Lukas Lambert; Ondrej Foltan; Jan Briza; Alena Lambertova; Pavel Harsa; Rohan Banerjee; Jan Daneš